GSK Can't Shake Calif. County's Avandia False Ad Claims

Law360, New York (February 26, 2014, 3:39 PM EST) -- A Pennsylvania federal judge on Tuesday denied GlaxoSmithKline PLC's bid to partially dismiss false advertising claims brought by Santa Clara County, Calif., over GSK's diabetes medication Avandia, rejecting its argument that the claims must be based on false advertising displayed within the county.

GSK had argued that a release included in a settlement between the company and the California attorney general in November 2012 that excluded claims for Santa Clara County residents limited the claims to residents exposed to false advertising within the county, but U.S....
To view the full article, register now.